Dolan James Lawrence, Executive Chairman and CEO, has engaged in a significant number of insider transactions across four companies, as disclosed in SEC Form 4 filings. His trading activity, spanning 66 transactions, reveals a clear bias toward selling, with total sales amounting to $50,582,180.82 compared to total purchases of $23,178,511.10. Notably, Lawrence has not executed any recent buys, and his recent sales activity has been concentrated in specific tickers, including SPHR, MSGS, and MSGE. On February 17, 2026, Lawrence conducted multiple transactions involving SPHR, including sales totaling $1,330,578.65 and $3,657,028.95, alongside dispositions valued at $7,314,024.31 and $2,485,765.70. Similarly, on September 15, 2025, he executed sales in MSGS totaling $2,384,797.00 and MSGE at $2,452,994.44, while also disposing of SPHR shares worth $4,764,537.83. These transactions underscore a consistent pattern of reducing holdings in these companies. Lawrence’s trading activity, particularly the absence of recent buys and the focus on sales, suggests a strategic shift in his portfolio allocation. The data reflects a measured approach to divestment, with no indication of recent acquisitions across the companies he oversees.
AI-assisted summary